9
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hearing loss and COVID-19: A note

      letter
      a , * , b , c
      American Journal of Otolaryngology
      Elsevier Inc.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear Editor, COVID-19 is a new pandemic caused by a novel coronavirus, SARS CoV. This disease already causes a big pandemic and affects more than 120 countries. This disease firstly occurred in a province of China then spread worldwide [1]. Clinically, the disease usually presented with respiratory illness and death is a possible outcome [2,3]. The effect of COVID-19 is an interesting issue in audiology. In this report, the author would like to share preliminary observations from Thailand, the second country that COVID-19 occurred after China [4]. At present (15th March 2020), 82 COVID-19 patients with 1 dead case are statistically recorded in Thailand. One (1.22%) from these patients, an old female, has coincidence of neurosensory hearing loss. This patient was cared by standard respiratory care and recovery. There is no observation on change of hearing loss problem in this case. In fact, auditory complication due to coronavirus is little mentioned in the literature. In previous report on other coronavirus infection, brainstem involvement is observed [5] and the neuro-auditory problem is a possible. Further study on the auditory problem in patients with COVID-19 is very interesting. This is a short preliminary report but it is the first world report on interrelationship between COVID-19 and hearing loss. Declaration of competing interest None.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

          Background Studies have reminded that cardiovascular metabolic comorbidities made patients more susceptible to suffer 2019 novel corona virus (2019-nCoV) disease (COVID-19), and exacerbated the infection. The aim of this analysis is to determine the association of cardiovascular metabolic diseases with the development of COVID-19. Methods A meta-analysis of eligible studies that summarized the prevalence of cardiovascular metabolic diseases in COVID-19 and compared the incidences of the comorbidities in ICU/severe and non-ICU/severe patients was performed. Embase and PubMed were searched for relevant studies. Results A total of six studies with 1527 patients were included in this analysis. The proportions of hypertension, cardia-cerebrovascular disease and diabetes in patients with COVID-19 were 17.1%, 16.4% and 9.7%, respectively. The incidences of hypertension, cardia-cerebrovascular diseases and diabetes were about twofolds, threefolds and twofolds, respectively, higher in ICU/severe cases than in their non-ICU/severe counterparts. At least 8.0% patients with COVID-19 suffered the acute cardiac injury. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients. Conclusion Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Diabetes and COVID‐19

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Emerging new coronavirus infection in Wuhan, China: Situation in early 2020

              W Hsia (2020)
                Bookmark

                Author and article information

                Contributors
                Journal
                Am J Otolaryngol
                Am J Otolaryngol
                American Journal of Otolaryngology
                Elsevier Inc.
                0196-0709
                1532-818X
                2 April 2020
                2 April 2020
                : 102473
                Affiliations
                [a ]TWS Medical Center, Bangkok, Thailand
                [b ]Dr DY Patil University, Pune, India
                [c ]Hainan Medical University, Haikou, China
                Author notes
                [* ]Corresponding author. wonsriwi@ 123456gmail.com
                Article
                S0196-0709(20)30155-1 102473
                10.1016/j.amjoto.2020.102473
                7132500
                32276732
                6f2295c5-861e-417f-bab4-f9986f98d261
                © 2020 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 19 March 2020
                Categories
                Article

                Comments

                Comment on this article